Exploring the Impact of Physical Activity on Cryptogenic Steatotic Liver Disease: A Nigerian Case-Control Study.
Main Article Content
Keywords
Cryptogenic steatotic liver disease, physical activity, sedentary lifestyle, case-control study, Nigeria
Abstract
Background: Cryptogenic steatotic liver disease (CSLD) is a novel subject where the liver has significant steatosis but without a known cause or abnormal cardiometabolic risk factors. It is a growing global health concern with an unclear etiology. Despite the increasing prevalence of CSLD, particularly in regions undergoing rapid urbanization and lifestyle changes, there is limited research on its risk factors in Nigeria. This study investigated the relationship between physical activity and CSLD in a Nigerian population.
Methodology: A case-control study was conducted in tertiary institutions in Zaria, Nigeria. A total of 362 participants were recruited, comprising 181 individuals with CSLD diagnosed via ultrasound and 181 age- and sex-matched healthy controls. Lifestyle, anthropometric, and biochemical data were collected, with physical activity levels classified into sedentary, mild, moderate, and strenuous categories. Statistical analyses, including chi-square tests and logistic regression, were performed to assess associations between physical activity and CSLD.
Results: There was no significant difference in age (p = 0.5578) or sex distribution (p = 0.9160) between CSLD cases and controls. However, a significant association was observed between CSLD severity and physical activity levels (χ² = 172.1, p < 0.0001). Sedentary individuals had a higher risk of CSLD, while moderate physical activity was the most protective (OR: 0.001, p < 0.001). These findings suggest that an inactive lifestyle is a strong risk factor for CSLD.
Conclusion: Sedentary behavior is an independent risk factor for CSLD, while regular physical activity, particularly moderate exercise, is protective. Public health initiatives promoting physical activity should be prioritized to mitigate CSLD progression and its complications. Further longitudinal research is needed to explore genetic predispositions and assess the long-term impact of lifestyle modifications on CSLD outcomes.
References
2. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-1986. https://doi.org/10.1002/hep.33061
3. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67:328–57.
4. Sainani KL. Calculating sample size for a case-control study. 2008; Available at: https://web.standford.edu/~kcobb/hrp261/lecture8.ppt.
5. Torres DM, Williams CD, Harrison SA. Features, Diagnosis, and Treatment of Non-alcoholic Fatty Liver Disease. Clinical Gastroentrology & Hepatology. 2012; 10:837-858.
6. Lupsor-Platon M, Stefanescu H, Mursan D. Non-invasive assessment of liver steatosis using ultrasound methods. Medical Ultrasonography. 2014; 16(3):236-245.
7. O'Donnell J, Smith-Byrne K, Velardo C. Self-reported and objectively measured physical activity in people with and without chronic heart failure: UK Biobank analysis. Open Heart. 2020;7:e001099.
8. Kim CW, Yun KE, Jung HS, Chang Y, Choi ES, Kwon MJ, Lee EH, Woo EJ, Kim NH, Shin H, Ryu S. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol. 2013 Aug;59(2):351-7. doi: 10.1016/j.jhep.2013.03.035.
9. Seo Y, Sung GH, Lee S, Han KJ. Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease. Ann Hepatol. 2022 May-Jun;27(3):100690. doi: 10.1016/j.aohep.2022.100690.
10. Tseng CH., Chen CH, Chen SJ. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. Sleep Medicine. 2014;15(1):103-108.
11. Park KW, Park SY, Lee YS. Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease. Annals of Hepatology. 2023;16:100448.
12. Mishra A, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. J Clin Exp Hepatol. 2012;2(2):135–44.
13. Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, et al. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023;55(9):1717-1726.
14. Ryu S, Chang Y, Jung HS, Yun KE, Kwon MJ, Choi Y, Kim CW, Cho J, Suh BS, Cho YK, Chung EC, Shin H, Kim YS. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. J Hepatol. 2015 Nov;63(5):1229-37. doi: 10.1016/j.jhep.2015.07.010.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.